10.400
+0,00%
2026-10-14
Fundamental Analysis
37 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -33.0% | +88.0% | 2 / 3 | -12.1% | +1.85 pp | -0.31 pp | +14.9% | 4.82 | 5.51 | 695 | −12,1% | 7,0 | −33,0% | 5.51 | 10.53 | −47,7% |
| Pts | 0 | 12 | 8 | 0 | 8 | 4 | 0 | -4 | 12 | |||||||
Valuation annotation:Price: 10.400 (close price on 2026-10-14)EPS (TTM): 1.888
Financial charts
1.Revenue & growth
VND bn695Q2/26
1.Revenue & growth
VND bn695Q2/26
2.Profit & growth
VND bn3,53Q2/26
3.Profit mix (Penman)
VND bn37,1Q2/26
4.Margins & cost structure
%7.6%Q2/26
5.Returns & cash cycle
% · days4.6%Q2/26
6.Earnings quality & cash
VND bn
7.Asset structure
VND bn2.566Q2/26
8.Funding & debt health
VND bn · times2.566Q2/26
9.Revenue backlog
VND bn49,5Q2/26
10.Valuation
times · %6,1×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %193Q2/26
Adjusted EPS growth, latest quarter
-66.2%
Average adjusted EPS growth, 3 quarters
76.9%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26